Microbot Medical (MBOT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Microbot Medical (MBOT) is Moderate Underperform.

The composite score behind that read is -0.21, weighing +0.26 of bullish evidence against -0.26 bearish.

Microbot Medical last closed at $1.07, -7.76% on the session.

Against the IVW growth benchmark the position is -8.68% over the forecast window.

The read is built from 13 underlying insights — 2 bullish and 11 bearish.

Agreement across those insights is 85%.

7 graded predictions for MBOT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Microbot Medical in the 26th percentile on return on equity, where 100 is best.

Microbot Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $77.91M.

StockMap tracks Microbot Medical as the 106th largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Microbot Medical ranks 72nd of 133 in the group, against a group median of -0.21.